• Dominique Jordan, Josep M Guiu-Segura, Gonçalo Sousa-Pinto, and Lin-Nam Wang.
• President International Pharmaceutical Federation (FIP). LinNam@fip.org.
• Farm Hosp. 2021 Feb 22; 45 (2): 89-95.

AbstractAll over the world pharmacists are standing up to the challenge of COVID- 19 and showing their commitment to the communities they serve. As the COVID-19 pandemic has tested global health systems to their limits, pharmacy professionals have shown themselves to be an integral part of them. Community pharmacists have supported government initiatives to control the pandemic and have ensured patients continued to receive their medicines. Hospital pharmacists have been moving beyond their specialties to help provide critical care to patients while dealing with ICU drug shortages. Pharmaceutical scientists have been involved in finding effective vaccines and identifying effective treatments. In short, the pharmacy profession has been demonstrating expertise, strength, courage and dedication to care at the highest level. The International Pharmaceutical Federation (FIP), which represents the pharmacy profession globally, has a mission to advance pharmacy worldwide by sharing best pharmacy practice and innovation with the world. In this article, it describes how pharmacy has stepped up during the COVID‑19 crisis by giving examples from several countries. It highlights, for example, how virtual practice became more prominent as face-to-face meetings became impossible, how pharmacists' scope of practice has been extended, and how pharmacy educators have embraced digital technologies to teach and assess students remotely. In particular, the article highlights pharmacists' involvement in the COVID-19 vaccination programmes in Australia, Canada, Germany, Ireland, Switzerland, the UK and the USA. As a result of all this, FIP sees an exciting future for the profession. Health ministers and heads of state have been praising pharmacists for their service, and FIP wants governments to translate this recognition into support for expanded roles and scientific research. It continues to gather data and intelligence to support an expansion of pharmacy practice, education and pharmaceutical workforce that builds on the profession's scientific base. All these advances are supported by scientific studies about our specialty. Finally, FIP expresses its worries about equity of access to medicines during the pandemic, as younger, healthier people in rich countries are vaccinated before people at greater risk in poor countries. It insists it will continue to advocate on this topic as a core component of its global vision. In this article, we share with readers a snapshot of how our profession around the world has adapted to the challenges posed by the COVID-19 pandemic, and our thoughts on the how it is affecting the evolution of pharmacy practice.Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

6 keywords...

hide…